Joseph N. Contessa, Ph.D. - Publications

Affiliations: 
2002 Virginia Commonwealth University, Richmond, VA, United States 
Area:
Molecular Biology, Cell Biology, Medical Biophysics, Oncology

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, ... ... Contessa JN, et al. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016697144. PMID 28113019 DOI: 10.1200/JCO.2016.69.7144  0.4
2016 Lopez-Sambrooks C, Shrimal S, Khodier C, Flaherty DP, Rinis N, Charest JC, Gao N, Zhao P, Wells L, Lewis TA, Lehrman MA, Gilmore R, Golden JE, Contessa JN. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. Nature Chemical Biology. PMID 27694802 DOI: 10.1038/nchembio.2194  0.64
2016 Contessa JN, Johung KL, Goldberg S, Chiang VL. Reply to M.S. Copur et al and to M.C. Chamberlain. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27114599 DOI: 10.1200/JCO.2016.67.2816  0.64
2015 Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, ... Contessa JN, et al. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26438117 DOI: 10.1200/JCO.2015.62.0138  0.64
2015 Goldberg SB, Contessa JN, Omay SB, Chiang V. Lung Cancer Brain Metastases. Cancer Journal (Sudbury, Mass.). 21: 398-403. PMID 26389765 DOI: 10.1097/PPO.0000000000000146  0.64
2014 Cazet A, Charest J, Bennett DC, Sambrooks CL, Contessa JN. Mannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity. Plos One. 9: e110345. PMID 25314669 DOI: 10.1371/journal.pone.0110345  0.64
2013 Petrulli JR, Sullivan JM, Zheng MQ, Bennett DC, Charest J, Huang Y, Morris ED, Contessa JN. Quantitative analysis of [11C]-erlotinib PET demonstrates specific binding for activating mutations of the EGFR kinase domain. Neoplasia (New York, N.Y.). 15: 1347-53. PMID 24403856 DOI: 10.1593/neo.131666  0.64
2013 Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5523-32. PMID 23897899 DOI: 10.1158/1078-0432.CCR-13-0836  0.64
2013 Bennett DC, Charest J, Sebolt K, Lehrman M, Rehemtulla A, Contessa JN. High-throughput screening identifies aclacinomycin as a radiosensitizer of EGFR-mutant non-small cell lung cancer. Translational Oncology. 6: 382-91. PMID 23730419 DOI: 10.1593/tlo.13232  0.64
2013 Johung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer. Head & Neck. 35: 852-7. PMID 22740347 DOI: 10.1002/hed.23041  0.64
2011 Khan AP, Contessa JN, Nyati MK, Ross BD, Rehemtulla A. Molecular imaging of epidermal growth factor receptor kinase activity. Analytical Biochemistry. 417: 57-64. PMID 21693098 DOI: 10.1016/j.ab.2011.05.040  0.64
2010 Contessa JN, Bhojani MS, Freeze HH, Ross BD, Rehemtulla A, Lawrence TS. Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3205-14. PMID 20413434 DOI: 10.1158/1078-0432.CCR-09-3331  0.64
2009 Contessa JN, Griffith KA, Wolff E, Ensminger W, Zalupski M, Lawrence TS, Ben-Josef E. Radiotherapy for pancreatic neuroendocrine tumors. International Journal of Radiation Oncology, Biology, Physics. 75: 1196-200. PMID 19327905 DOI: 10.1016/j.ijrobp.2008.12.044  0.64
2008 Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Research. 68: 3803-9. PMID 18483264 DOI: 10.1158/0008-5472.CAN-07-6389  0.64
2008 Contessa JN, Hamstra DA. Revoking the privilege: targeting HER2 in the central nervous system. Molecular Pharmacology. 73: 271-3. PMID 17981994 DOI: 10.1124/mol.107.042986  0.64
2007 Spalding AC, Contessa JN. Using ErbB2-negative status to direct therapy in locally advanced breast cancer. Cancer Biology & Therapy. 6: 463-4. PMID 17471028  0.64
2006 Contessa JN, Abell A, Valerie K, Lin PS, Schmidt-Ullrich RK. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells. International Journal of Radiation Oncology, Biology, Physics. 65: 851-8. PMID 16751066 DOI: 10.1016/j.ijrobp.2006.02.025  0.64
2006 Contessa JN, Roberson PL. Targeted radiation for melanoma: alpha therapy prepares for a beta test. Cancer Biology & Therapy. 5: 118-9. PMID 16491043  0.64
2006 Contessa JN, Abell A, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation. Breast Cancer Research and Treatment. 95: 17-27. PMID 16267617 DOI: 10.1007/s10549-005-9023-9  0.64
2003 Lammering G, Hewit TH, Valerie K, Lin PS, Contessa JN, Schmidt-Ullrich RK. Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours. International Journal of Radiation Biology. 79: 561-8. PMID 14530165 DOI: 10.1080/0955300031000102632  0.64
2003 Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene. 22: 5855-65. PMID 12947392 DOI: 10.1038/sj.onc.1206698  0.64
2003 Lammering G, Hewit TH, Valerie K, Contessa JN, Amorino GP, Dent P, Schmidt-Ullrich RK. EGFRvIII-mediated radioresistance through a strong cytoprotective response. Oncogene. 22: 5545-53. PMID 12944901 DOI: 10.1038/sj.onc.1206788  0.64
2002 Contessa JN, Hampton J, Lammering G, Mikkelsen RB, Dent P, Valerie K, Schmidt-Ullrich RK. Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene. 21: 4032-41. PMID 12037685 DOI: 10.1038/sj.onc.1205500  0.64
2001 Lammering G, Lin PS, Contessa JN, Hampton JL, Valerie K, Schmidt-Ullrich RK. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. International Journal of Radiation Oncology, Biology, Physics. 51: 775-84. PMID 11697324 DOI: 10.1016/S0360-3016(01)01714-X  0.64
2001 Lammering G, Hewit TH, Hawkins WT, Contessa JN, Reardon DB, Lin PS, Valerie K, Dent P, Mikkelsen RB, Schmidt-Ullrich RK. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. Journal of the National Cancer Institute. 93: 921-9. PMID 11416113  0.64
2001 Lammering G, Valerie K, Lin PS, Mikkelsen RB, Contessa JN, Feden JP, Farnsworth J, Dent P, Schmidt-Ullrich RK. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 682-90. PMID 11297265  0.64
1999 Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G, Lin PS. Molecular mechanisms of radiation-induced accelerated repopulation. Radiation Oncology Investigations. 7: 321-30. PMID 10644055 DOI: 10.1002/(SICI)1520-6823(1999)7:6<321::AID-ROI2>3.0.CO;2-Q  0.64
1999 Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 18: 4756-66. PMID 10467423 DOI: 10.1038/sj.onc.1202849  0.64
1999 Contessa JN, Reardon DB, Todd D, Dent P, Mikkelsen RB, Valerie K, Bowers GD, Schmidt-Ullrich RK. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 405-11. PMID 10037190  0.64
1997 Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, Contessa JN, Rorrer WK, Chen PB. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 15: 1191-7. PMID 9294612 DOI: 10.1038/sj.onc.1201275  0.64
Show low-probability matches.